Related references
Note: Only part of the references are listed.Plasma Testosterone Levels in Rats under Various Conditions
F. Stahl et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
2-methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells
C Perez-Stable
CANCER LETTERS (2006)
Inhibitors of 5 alpha-reductase in the treatment of benign prostatic hyperplasia
TH Tarter et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Synthesis of 7α-hydroxy-dehydroepiandrosterone and 7β-hydroxy-dehydroepiandrosterone
HP Li et al.
STEROIDS (2005)
A Vitex agnus-castus extract inhibits cell growth and induces apoptosis in prostate epithelial cell lines
M Weisskopf et al.
PLANTA MEDICA (2005)
A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells
LK Gediya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function
FC Lowe
BJU INTERNATIONAL (2005)
Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer
V Gududuru et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents.: Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-β-D-glucopyranosyl]-5H,13H-benzo[b]-thienyl[2,3-α]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model
BN Balasubramanian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Selective non-steroidal inhibitors of 5 alpha-reductase type 1
EG Occhiato et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
New benzo[g]isoquinoline-5,10-diones and dihydrothieno [2,3-b]naphtho-4,9-dione derivatives:: Synthesis and biological evaluation as potential antitumoral agents
I Gomez-Monterrey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
The pathophysiology of benign prostatic hyperplasia
B Djavan et al.
DRUGS OF TODAY (2002)
Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity
SF Brady et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells
CM Jakobsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy
VM Garsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
New progesterone esters as 5α-reductase inhibitors
M Cabeza et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4):: Synthesis and growth inhibitory effects on human prostate cancer cells
A Valasinas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α-hydroxylase/C17-20-lyase) and 5α-reductase types 1 and 2
RW Hartmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Apoptosis in prostate carcinogenesis - A growth regulator and a therapeutic target
EM Bruckheimer et al.
CELL AND TISSUE RESEARCH (2000)
Share Paper
